Tuberculous meningitis: Many questions, too few answers

Lancet Neurology

Volumn 4, Issue 3, 2005, Pages 160-170

  Thwaites, Guy E ^a,b,d   Hien, Tran Tinh ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ETHAMBUTOL; ISONIAZID; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC RESISTANCE; BACTERIOLOGY; BRAIN VENTRICLE PERITONEUM SHUNT; CLINICAL FEATURE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DISABILITY; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCEPHALUS; LABORATORY DIAGNOSIS; LUMBAR PUNCTURE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; TUBERCULOUS MENINGITIS;

EID: 13944280686     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(05)70019-3     Document Type: Review

References (98)

1. Green PH. Tubercular meningitis. Lancet. II:1836;232-235
2. Koch R. Die aetiologie der tuberculosis. Berlin Klinische Wochenschrift. 19:1882;221-230
3. Rich AR, McCordock HA. The pathogenesis of tuberculous meningitis. Bull John Hopkins Hosp. 52:1933;5-37
4. Girgis NI, Sultan Y, Farid Z, et al. Tuberculosis meningitis, Abbassia Fever Hospital Naval Medical Research Unit No 3, Cairo, Egypt, from 1976 to 1996. Am J Trop Med Hyg. 58:1998;28-34
5. Hosoglu S, Ayaz C, Geyik MF, Kokoglu OF, Ceviz A. Tuberculous meningitis in adults: an eleven-year review. Int J Tuberc Lung Dis. 2:1998;553-557
6. Farinha NJ, Razali KA, Holzel H, Morgan G, Novelli VM. Tuberculosis of the central nervous system in children: a 20-year survey. J Infect. 41:2000;61-68
7. Kent SJ, Crowe SM, Yung A, Lucas CR, Mijch AM. Tuberculous meningitis: a 30-year review. Clin Infect Dis. 17:1993;987-994
8. Verdon R, Chevret S, Laissy JP, Wolff M. Tuberculous meningitis in adults: review of 48 cases. Clin Infect Dis. 22:1996;982-988
9. Davis LE, Rastogi KR, Lambert LC, Skipper BJ. Tuberculous meningitis in the southwest United States: a community-based study. Neurology. 43:1993;1775-1778
10. Dastur DK, Manghani DK, Udani PM. Pathology and pathogenetic mechanisms in neurotuberculosis. Radiol Clin North Am. 33:1995;733-752
11. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol. 19:2001;93-129
12. Rook GA, Taverne J, Leveton C, Steele J. The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology. 62:1987;229-234
13. Sharief MK, Ciardi M, Thompson EJ. Blood-brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor-alpha but not interleukin-1 beta. J Infect Dis. 166:1992;350-358
14. Tsenova L, Bergtold A, Freedman VH, Young RA, Kaplan G. Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc Natl Acad Sci USA. 96:1999;5657-5662
15. Thwaites GE, Simmons CP, Than Ha Quyen N, et al. Pathophysiology and prognosis in Vietnamese adults with tuberculous meningitis. J Infect Dis. 188:2003;1105-1115
16. Tsenova L, Sokol K, Freedman VH, Kaplan G. A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death. J Infect Dis. 177:1998;1563-1572
17. Schoeman JF, Springer P, Ravenscroft A, et al. Adjunctive thalidomide therapy of childhood tuberculous meningitis: possible anti-inflammatory role. J Child Neurol. 15:2000;497-503
18. Schoeman JF, Springer P, van Rensburg AJ, et al. Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study. J Child Neurol. 19:2004;250-257
19. Laguna F, Adrados M, Ortega A, Gonzalez-Lahoz JM. Tuberculous meningitis with acellular cerebrospinal fluid in AIDS patients. Aids. 6:1992;1165-1167
20. Karstaedt AS, Valtchanova S, Barriere R, Crewe-Brown HH. Tuberculous meningitis in South African urban adults. Q J Med. 91:1998;743-747
21. Jeren T, Beus I. Characteristics of cerebrospinal fluid in tuberculous meningitis. Acta Cytol. 26:1982;678-680
22. Thwaites GE, Chau TT, Farrar JJ. Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol. 42:2004;378-379
23. Dieli F, Sireci G, Di Sano C, Champagne E, Fournie JJ, Salerno JI. Predominance of Vgamma9/Vdelta2 T lymphocytes in the cerebrospinal fluid of children with tuberculous meningitis: reversal after chemotherapy. Mol Med. 5:1999;301-312
24. British Medical Research Council. Streptomycin treatment of tuberculous meningitis. BMJ. I:1948;582-597
25. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet. 2:1974;81-84
26. Hosoglu S, Geyik MF, Balik I, et al. Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis. 6:2002;64-70
27. Kocen RS, Parsons M. Neurological complications of tuberculosis: some unusual manifestations. Q J Med. 39:1970;17-30
28. Udani PM, Parekh UC, Dastur DK. Neurological and related syndromes in CNS tuberculosis: clinical features and pathogenesis. J Neurol Sci. 14:1971;341-357
29. Alarcon F, Duenas G, Cevallos N, Lees AJ. Movement disorders in 30 patients with tuberculous meningitis. Mov Disord. 15:2000;561-569
30. Dastur DK, Udani PM. The pathology and pathogenesis of tuberculous encephalopathy. Acta Neuropathol (Berl). 6:1966;311-326
31. Dastur DK. The pathology and pathogenesis of tuberculous encephalopathy and myeloradiculopathy: a comparison with allergic encephalomyelitis. Childs Nerv Syst. 2:1986;13-19
32. Udani PM, Dastur DK. Tuberculous encephalopathy with and without meningitis: clinical features and pathological correlations. J Neurol Sci. 10:1970;541-561
33. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 351:2004;1741-1751
34. Dastur DK. Neurosurgically relevant aspects of pathology and pathogenesis of intracranial and intraspinal tuberculosis. Neurosurg Rev. 6:1983;103-110
35. Hernandez-Albujar S, Arribas JR, Royo A, Gonzalez-Garcia JJ, Pena JM, Vazquez JJ. Tuberculous radiculomyelitis complicating tuberculous meningitis: case report and review. Clin Infect Dis. 30:2000;915-921
36. Rapoport S, West CD, Brodsky WA. Salt losing conditions; the renal defect in tuberculous meningitis. J Lab Clin Med. 37:1951;550-561
37. Cort JH. Cerebral salt wasting. Lancet. 266:1954;752-754
38. Schwartz WB, Bennett W, Curelop S, Bartter FC. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med. 23:1957;529-542
39. Cotton MF, Donald PR, Schoeman JF, Van Zyl LE, Aalbers C, Lombard CJ. Raised intracranial pressure, the syndrome of inappropriate antidiuretic hormone secretion, and arginine vasopressin in tuberculous meningitis. Childs Nerv Syst. 9:1993;10-15. discussion 15-16.
40. Narotam PK, Kemp M, Buck R, Gouws E, van Dellen JR, Bhoola KD. Hyponatremic natriuretic syndrome in tuberculous meningitis: the probable role of atrial natriuretic peptide. Neurosurgery. 34:1994;982-988
41. Dass R, Nagaraj R, Murlidharan J, Singhi S. Hyponatraemia and hypovolemic shock with tuberculous meningitis. Indian J Pediatr. 70:2003;995-997
42. Cotton MF, Donald PR, Schoeman JF, Aalbers C, Van Zyl LE, Lombard C. Plasma arginine vasopressin and the syndrome of inappropriate antidiuretic hormone secretion in tuberculous meningitis. Pediatr Infect Dis J. 10:1991;837-842
43. Sakarcan A, Bocchini J. Jr. The role of fludrocortisone in a child with cerebral salt wasting. Pediatr Nephrol. 12:1998;769-771
44. Smith J, Godwin-Austen R. Hypersecretion of anti-diuretic hormone due to tuberculous meningitis. Postgrad Med J. 56:1980;41-44
45. Berenguer J, Moreno S, Laguna F, et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med. 326:1992;668-672
46. Katrak SM, Shembalkar PK, Bijwe SR, Bhandarkar LD. The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci. 181:2000;118-126
47. Fallon RJ, Kennedy DH. Treatment and prognosis in tuberculous meningitis. J Infect. 3:1981;39-44
48. Kalita J, Misra UK. Outcome of tuberculous meningitis at 6 and 12 months: a multiple regression analysis. Int J Tuberc Lung Dis. 3:1999;261-265
49. van den Bos F, Terken M, Ypma L, et al. Tuberculous meningitis and miliary tuberculosis in young children. Trop Med Int Health. 9:2004;309-313
50. Tung YR, Lai MC, Lui CC, et al. Tuberculous meningitis in infancy. Pediatr Neurol. 27:2002;262-266
51. Kumar R, Singh SN, Kohli N. A diagnostic rule for tuberculous meningitis. Arch Dis Child. 81:1999;221-224
52. Thwaites GE, Chau TT, Stepniewska K, et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet. 360:2002;1287-1292
53. Bernaerts A, Vanhoenacker FM, Parizel PM, et al. Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur Radiol. 13:2003;1876-1890
54. Kumar R, Kohli N, Thavnani H, Kumar A, Sharma B. Value of CT scan in the diagnosis of meningitis. Indian Pediatr. 33:1996;465-468
55. Andronikou S, Smith B, Hatherhill M, Douis H, Wilmshurst J. Definitive neuroradiological diagnostic features of tuberculous meningitis in children. Pediatr Radiol. 34:2004;876-885
56. Offenbacher H, Fazekas F, Schmidt R, et al. MRI in tuberculous meningoencephalitis: report of four cases and review of the neuroimaging literature. J Neurol. 238:1991;340-344
57. Tartaglione T, Di Lella GM, Cerase A, Leone A, Moschini M, Colosimo C. Diagnostic imaging of neurotuberculosis. Rays. 23:1998;164-180
58. Stewart SM. The bacteriological diagnosis of tuberculous meningitis. J Clinical Pathology. 6:1953;241-242
59. Garg RK. Tuberculosis of the central nervous system. Postgrad Med J. 75:1999;133-140
60. Kennedy DH, Fallon RJ. Tuberculous meningitis. JAMA. 241:1979;264-268
61. Pai M, Flores LL, Pai N, Hubbard A, Riley LW, Colford JM. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 3:2003;633-643
62. Thwaites GE, Caws M, Chau TT, et al. Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol. 42:2004;996-1002
63. Donald PR, Victor TC, Jordaan AM, Schoeman JF, van Helden PD. Polymerase chain reaction in the diagnosis of tuberculous meningitis. Scand J Infect Dis. 25:1993;613-617
64. Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis. 3:1999;S231-S279
65. Mitchison DA. Role of individual drugs in the chemotherapy of tuberculosis. Int J Tuberc Lung Dis. 4:2000;796-806
66. British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax. 53:1998;536-548
67. Centers for Disease Control. Treatment of tuberculosis. MMWR Recomm Rep. 52:2003;1-77
68. Bobrowitz ID. Ethambutol in tuberculous meningitis. Chest. 61:1972;629-632
69. Ellard GA, Humphries MJ, Allen BW. Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis. Am Rev Respir Dis. 148:1993;650-655
70. Donald PR, Seifart HI. Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis. J Pediatr. 115:1989;483-486
71. van Loenhout-Rooyackers JH, Keyser A, Laheij RJ, Verbeek AL, van der Meer JW. Tuberculous meningitis: is a 6-month treatment regimen sufficient? Int J Tuberc Lung Dis. 5:2001;1028-1035
72. Humphries M. The management of tuberculous meningitis. Thorax. 47:1992;577-581
73. Hong Kong Chest Service/British Medical Research Council. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide: results at 30 months. Am Rev Respir Dis. 143:1991;700-706
74. Shane SJ, Riley C. Tuberculous meningitis: combined therapy with cortisone and antimicrobial agents. N Engl J Med. 249:1953;829-834
75. Ashby M, Grant H. Tuberculous meningitis treated with cortisone. Lancet. 1:1955;65-66
76. Lepper MH, Spies HW. The present status of the treatment of tuberculosis of the central nervous system. Ann N Y Acad Med. 106:1963;106-123
77. O'Toole RD, Thornton GF, Mukherjee MK, Nath RL. Dexamethasone in tuberculous meningitis: relationship of cerebrospinal fluid effects to therapeutic efficacy. Ann Intern Med. 70:1969;39-48
78. Escobar JA, Belsey MA, Duenas A, Medina P. Mortality from tuberculous meningitis reduced by steroid therapy. Pediatrics. 56:1975;1050-1055
79. Girgis NI, Farid Z, Kilpatrick ME, Sultan Y, Mikhail IA. Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J. 10:1991;179-183
80. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics. 99:1997;226-231
81. Prasad K, Volmink J, Menon GR. Steroids for treating tuberculous meningitis. Cochrane Database Syst Rev. 3:2000;CD00224
82. Quagliarello V. Adjunctive steroids for tuberculous meningitis: more evidence, more questions. N Engl J Med. 351:2004;1792-1794
83. Schoeman JF, Elshof JW, Laubscher JA, Janse van Rensburg A, Donald PR. The effect of adjuvant steroid treatment on serial cerebrospinal fluid changes in tuberculous meningitis. Ann Trop Paediatr. 21:2001;299-305
84. van der Flier M, Hoppenreijs S, van Rensburg AJ, et al. Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis. Pediatr Infect Dis J. 23:2004;608-613
85. Schoeman J, Donald P, van Zyl L, Keet M, Wait J. Tuberculous hydrocephalus: comparison of different treatments with regard to ICP, ventricular size and clinical outcome. Dev Med Child Neurol. 33:1991;396-405
86. Lamprecht D, Schoeman J, Donald P, Hartzenberg H. Ventriculoperitoneal shunting in childhood tuberculous meningitis. Br J Neurosurg. 15:2001;119-125
87. Palur R, Rajshekhar V, Chandy MJ, Joseph T, Abraham J. Shunt surgery for hydrocephalus in tuberculous meningitis: a long-term follow-up study. J Neurosurg. 74:1991;64-69
88. Schoeman JF, Laubscher JA, Donald PR. Serial lumbar CSF presure measurements and cranial computed tomographic findings in childhood tuberculous meningitits. Childs Nerv Syst. 16:2000;203-208
89. Mathew JM, Rajshekhar V, Chandy MJ. Shunt surgery in poor grade patients with tuberculous meningitis and hydrocephalus: effects of response to external ventricular drainage and other variables on long term outcome. J Neurol Neurosurg Psychiatry. 65:1998;115-118
90. Patel VB, Padayatchi N, Bhigjee AI, et al. Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa. Clin Infect Dis. 38:2004;851-856
91. Thwaites GE, Chau TT, Caws M, et al. Isoniazid resistance, mycobacterial genotype and outcome in Vietnamese adults with tuberculous meningitis. Int J Tuberc Lung Dis. 6:2002;865-871
92. Daikos GL, Cleary T, Rodriguez A, Fischl MA. Multidrug-resistant tuberculous meningitis in patients with AIDS. Int J Tuberc Lung Dis. 7:2003;394-398
93. Mokrousov I, Otten T, Vyshnevskiy B, Narvskaya O. Allele-specific rpoB PCR assays for detection of rifampin-resistant Mycobacterium tuberculosis in sputum smears. Antimicrob Agents Chemother. 47:2003;2231-2235
94. Johansen IS, Lundgren B, Sosnovskaja A, Thomsen Vs VO. Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay. J Clin Microbiol. 41:2003;4454-4456
95. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet. 362:2003;887-899
96. Crofton J, Chaulet P, Maher D. Guidelines for the management of drug-resistant tuberculosis. 1997;WHO TB, Geneva
97. Berning SE, Cherry TA, Iseman MD. Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report. Clin Infect Dis. 32:2001;643-646
98. Nau R, Prange HW, Martell J, Sharifi S, Kolenda H, Bircher J. Penetration of ciprofloxacin into the cerebrospinal fluid of patients with uninflamed meninges. J Antimicrob Chemother. 25:1990;965-973